Study Comparing Three Doses of MDMA Along With Psychotherapy in Veterans With Posttraumatic Stress Disorder
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to provide information on whether psychotherapy ("talk therapy")
combined with the drug MDMA is safe and helpful for subjects with posttraumatic stress
disorder (PTSD). The study will compare the effects of a low, a medium and a full dose of
MDMA on symptoms of PTSD in 24 veterans, firefighters or police officers. MDMA dose will be
assigned at random, and the investigators and the subject will not know the dose given. The
researchers will also investigate depression symptoms. The researchers believe that the full
dose of MDMA will produce a greater reduction in PTSD symptoms than the two lower doses.
Phase:
Phase 2
Details
Lead Sponsor:
Multidisciplinary Association for Psychedelic Studies